This study is looking at a potential new treatment of inflammatory disorders (e.g. Chronic fever syndromes,) and diseases of the nervous system (e.g. Alzheimer’s).
The medication is designed to treat these disorders by inhibiting the over-activation of the immune system. The purpose of this study is to investigate how this medication is absorbed and processed in a healthy body.
This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.
Call us on 1800 243 733 to discuss your eligibility today!